, rudolf valento, professor at the university of vienna, he is a foreign member of the ras of our academyonomic effect - this of course sounds a little strange, but if there are 30-40% of allergy sufferers, a huge number, i know that many leave when this flowering begins, your development is so, well, approximately, it can reduce how much the number of people getting sick, that’s how you see the positive socio-economic the consequences of your development, it seems to me that they can be directly significant, yes, that is, in fact, the market for the sale... of this vaccine, it is very large, very large, there are a lot of patients who are interested in receiving this vaccine and receiving treatment of this vaccine, in addition, in addition, in our further studies, already at the third stage, even moving a little to the so -called post-registration study, we plan to look at the possibility of prevention. allergy to birch pollen with with the help of our vaccine, because it is impossible to use the whole protein, that is, an allergenic extract or allergoid, why? because if you introduce th